Associate Director, Oncology Clinical Biomarker Asset Lead, Translational Development

Associate Director, Oncology Clinical Biomarker Asset Lead, Translational Development

Join to apply for the Associate Director, Oncology Clinical Biomarker Asset Lead, Translational Development role at Bristol Myers Squibb
.

Challenging. Meaningful. Life‑changing. Those aren't words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it.

You'll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high‑achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide employees with the resources to pursue their goals, both at work and in their personal lives.

The Clinical Biomarker Asset Lead role will be responsible for development and execution of translational strategies in solid tumor oncology for assigned programs. The role acts as a lead scientist to implement and deliver on biomarker strategies for clinical programs, develop reports and publications on translational data generated to support asset development, and contribute to regulatory submissions. This individual will work on cross‑functional project teams to drive execution of translational/biomarker plans, collaborating with disease and lab scientists, and BMS members from clinical, medical, commercial, regulatory, and diagnostics.

The role also engages with external academic collaborators and Key Opinion Leaders (KOLs).

• Integrate translational research and clinical development, developing biomarker strategies in alignment with clinical development objectives, leading efforts for data generation and interpretation, and communicating results to the development teams.
• Partner with external and internal functions to coordinate execution of translational development deliverables.
• Engage functional groups to develop, champion, implement, and align biomarker strategies for development projects in support of overall R&D portfolio goals.
• Effectively engage with teams and matrix leadership to define, revise, and progress translational biomarker plans.
• Analyze progress, engage in critical thinking, and assert strong problem‑solving toward delivering key data and interpretations essential for decision making.
• Deliver high‑quality biomarker strategies for mechanism of action/resistance, target engagement, pharmacodynamics endpoints, and patient selection.
• Ensure biomarker plans meet established project standards.
• Align biomarker strategies with clinical operational plans and functional area capabilities to execute and deliver on robust translational biomarker data packages to support trial and program needs.
• Build productive relationships with team members that interact with the translational clinical biomarker group.
• Interface with functional areas to ensure strategic alignment and identify resources needed to deliver on biomarker goals.
• Engage with external collaborators and scientific KOLs to support translational goals.
• Communicate key biomarker program information, risks, and milestones, and manage information flow across team members.

• Ph.D. in Oncology/immunology or related field.
• 5‑8+ years of industry experience.
• 3‑5 years in oncology/biomarkers/translational or correlative research.
• Prior experience as Biomarker Lead for late‑stage clinical trials;
  Phase II/III experience required.
• Comprehensive knowledge of principles, concepts, and methodologies within drug discovery or clinical development.
• Significant understanding of translational research/medicine and clinical biomarkers in drug development.
• Demonstrated knowledge of oncology and/or tumor‑immunology disease biology.
• Regulatory submission experience in the solid tumor space highly desirable.
• Knowledge of the current and…